Ultrastructural and histomorphometric evaluations of gallium nitrate on bone in nude mice bearing a canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.
Gallium is a group IIIa transition metal that lowers serum calcium by an unknown mechanism and has been utilized in the treatment of cancer-associated hypercalcemia. The purpose of this study was to histomorphometrically investigate the ultrastructural effects of gallium nitrate on osteoclasts and osteoblasts in trabecular bone of normal nude mice and nude mice with humoral hypercalcemia of malignancy. Two groups of normal nude mice (n = 7 and n = 8, respectively) and two groups of hypercalcemic nude mice (n = 9) bearing a serially transplantable canine adenocarcinoma (CAC-8) were treated with vehicle or gallium nitrate. Osteoclasts were hypertrophied in vehicle-treated tumor-bearing nude mice as compared with vehicle-treated nontumor-bearing nude mice. Osteoclasts from tumor-bearing nude mice treated with gallium nitrate were significantly decreased in size and had fewer intracytoplasmic vesicles as compared with osteoclasts from vehicle-treated tumor-bearing nude mice. Degenerate osteoclasts, characterized by pyknotic nuclei and increased cytoplasmic vacuolation, were observed in both groups of gallium-treated nude mice. Osteoblasts from vehicle-treated tumor-bearing nude mice were hypertrophied and had extensive lamellar arrays of rough endoplasmic reticulum as compared with osteoblasts from vehicle-treated nontumor-bearing nude mice. Osteoblasts in gallium-treated nude mice (tumor-bearing and nontumor-bearing) were small and flattened with poorly developed cytoplasmic organelles. This investigation demonstrated that osteoclasts and osteoblasts in nude mice treated with gallium nitrate had ultrastructural evidence of decreased metabolic and functional activity. The results suggest that gallium nitrate lowers serum calcium by inhibiting osteoclastic bone resorption.
Okada
H
H
Department of Veterinary Pathobiology, Ohio State University, Columbus.
Merryman
J I
JI
Capen
C C
CC
Rosol
T J
TJ
D000230:Adenocarcinoma / Q000150:complications / Q000473:pathology / Q000662:veterinary*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use / Q000633:toxicity*; D001859:Bone Neoplasms / Q000150:complications / Q000473:pathology / Q000662:veterinary*; D001862:Bone Resorption; D002118:Calcium / Q000097:blood / Q000378:metabolism; D004195:Disease Models, Animal; D004283:Dog Diseases / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D004285:Dogs; D005708:Gallium / Q000627:therapeutic use / Q000633:toxicity*; D006934:Hypercalcemia / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000662:veterinary*; D008297:Male; D051379:Mice; D008819:Mice, Nude; D008854:Microscopy, Electron / Q000662:veterinary; D009368:Neoplasm Transplantation / Q000662:veterinary; D010006:Osteoblasts / Q000187:drug effects / Q000473:pathology / Q000648:ultrastructure; D010010:Osteoclasts / Q000187:drug effects / Q000473:pathology / Q000648:ultrastructure; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D005708:Gallium; D002118:Calcium; C027235:gallium nitrate